Faced with a diagnosis of advanced prostate cancer, Andy explored all his treatment options. He enrolled in an immunotherapy clinical trial. #CIM17 #Cancer #PatientStories
Andy passed away in September 2019 after a long battle with cancer. Immunotherapy extended his life for over three more active and happy years with his family.
This video is presented as part of the Cancer Research Institute Fifth Annual Cancer Immunotherapy Month awareness campaign in June 2017. Help us raise awareness of the lifesaving potential of immunotherapy for all types of cancer. Let’s fuel the next scientific discoveries and breakthrough treatments through learning, engagement, and storytelling.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers.
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.